Three-dimensional fibrous scaffolds made of a three-arm star poly(ε-caprolactone) were developed by employing a novel computer-aided wet-spinning apparatus to precisely control the deposition pattern of an extruded polymeric solution as a filament into a coagulation bath. Star poly(ε-caprolactone)/hydroxyapatite composite scaffolds composed of fibres with a porous morphology both in the outer surface and in the cross section were successfully produced with a layer-by-layer approach achieving good reproducibility of the internal architecture and external shape. Changes in processing parameters were used to fabricate scaffolds with different architectural parameters in terms of average pore size in the xy-axes (from 190 to 297 µm) and in the z-axis (from 54 to 126 µm) and porosity (in the range of 20%–60%). Based on the mechanical characterization, processing variations and hydroxyapatite loading have an influence on scaffold compression properties. Cell cultures, using a murine pre-osteoblast cell line, had good cell responses in terms of proliferation and osteoblastic differentiation. Thus, this technique appears to be an effective method for producing customized polymeric scaffolds for bone tissue engineering applications.
StockUAVacantiJP.Tissue engineering: current state and prospects. Annu Rev Med2001; 52: 443–451.
2.
HutmacherDWCoolS.Concepts of scaffold-based tissue engineering – the rationale to use solid free-form fabrication techniques. J Cell Mol Med2007; 11(4): 654–669.
3.
KimB-SMooneyDJ.Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol1998; 16(5): 224–230.
4.
KarageorgiouVKaplanD.Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials2005; 26(27): 5474–5491.
5.
PuppiDChielliniFPirasAM. Polymeric materials for bone and cartilage repair. Prog Polym Sci2010; 35(4): 403–440.
6.
SachlosECzernuszkaJT.Making tissue engineering scaffolds work. Review: the application of solid freeform fabrication technology to the production of tissue engineering scaffolds. Eur Cell Mater2003; 5: 29–40.
7.
MotaCPuppiDChielliniF. Additive manufacturing techniques for the production of tissue engineering constructs. J Tissue Eng Regen Med. doi: 10.1002/term.1635.
8.
TuzlakogluKReisRL.Chitosan-based scaffolds in orthopaedic applications. In: ReisRL (ed.) Natural-based polymers for biomedical applications. Cambridge: Woodhead, 2008, pp. 357–373.
9.
HeinemannCHeinemannSLodeA. In vitro evaluation of textile chitosan scaffolds for tissue engineering using human bone marrow stromal cells. Biomacromolecules2009; 10(5): 1305–1310.
10.
YilgorPTuzlakogluKReisRL. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Biomaterials2009; 30(21): 3551–3559.
11.
LeonorIBRodriguesMTGomesME. In situ functionalization of wet-spun fibre meshes for bone tissue engineering. J Tissue Eng Regen Med2011; 5(2): 104–111.
12.
TuzlakogluKPashkulevaIRodriguesMT. A new route to produce starch-based fiber mesh scaffolds by wet spinning and subsequent surface modification as a way to improve cell attachment and proliferation. J Biomed Mater Res A2010; 92(1): 369–377.
13.
PashkulevaILópez-PérezPMAzevedoHS. Highly porous and interconnected starch-based scaffolds: production, characterization and surface modification. Mater Sci Eng C Mater Biol Appl2010; 30(7): 981–989.
14.
GomesMESikavitsasVIBehraveshE. Effect of flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured on starch-based three-dimensional scaffolds. J Biomed Mater Res A2003; 67(1): 87–95.
15.
GomesMEBossanoCMJohnstonCM. In vitro localization of bone growth factors in constructs of biodegradable scaffolds seeded with marrow stromal cells and cultured in a flow perfusion bioreactor. Tissue Eng2006; 12(1): 177–188.
16.
PuppiDDinucciDBartoliC. Development of 3D wet-spun polymeric scaffolds loaded with antimicrobial agents for bone engineering. J Bioact Compat Polym2011; 26(5): 478–492.
17.
PuppiDPirasAMChielliniF. Optimized electro- and wet-spinning techniques for the production of polymeric fibrous scaffolds loaded with bisphosphonate and hydroxyapatite. J Tissue Eng Regen Med2011; 5(4): 253–263.
18.
PuppiDMotaCGazzarriM. Additive manufacturing of wet-spun polymeric scaffolds for bone tissue engineering. Biomed Microdevices2012; 14(6): 1115–1127.
19.
McKeeMGUnalSWilkesGL. Branched polyesters: recent advances in synthesis and performance. Prog Polym Sci2005; 30(5): 507–539.
20.
BurchardW.Solution properties of branched macromolecules. Adv Polym Sci1999; 143: 113–194.
21.
McKeeMGWilkesGLColbyRH. Correlations of solution rheology with electrospun fiber formation of linear and branched polyesters. Macromolecules2004; 37(5): 1760–1767.
22.
CelikAKemikliNOzturkR. Synthesis, characterization and thermal properties of a novel star polymer consisting of poly([epsilon]-caprolactone) arms emanating from an octa-functional porphyrazine core. React Funct Polym2009; 69(9): 705–713.
23.
BalakrishnanSKrishnanMDuboisP. Kinetic and thermodynamic considerations in the synthesis of a new three-arm poly(ε-caprolactone). Polym Eng Sci2004; 44(8): 1491–1497.
24.
BalakrishnanSKrishnanMNarayanR. Three-arm poly (ε-caprolactone) by extrusion polymerization. Polym Eng Sci2006; 46(3): 235–240.
25.
PuppiDDettaNPirasAM. Development of electrospun three-arm star poly(ε-caprolactone) meshes for tissue engineering applications. Macromol Biosci2010; 10(8): 887–897.
26.
MaPX.Biomimetic materials for tissue engineering. Adv Drug Deliv Rev2008; 60(2): 184–198.
27.
SopyanIMelMRameshS. Porous hydroxyapatite for artificial bone applications. Sci Technol Adv Mat2007; 8(1–2): 116–123.
28.
RezwanKChenQZBlakerJJ. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials2006; 27(18): 3413–3431.
KohY-HBaeC-JSunJ-J. Macrochanneled poly(ε-caprolactone)/hydroxyapatite scaffold by combination of bi-axial machining and lamination. J Mater Sci Mater Med2006; 17(9): 773–778.
31.
LandersRPfisterAHübnerU. Fabrication of soft tissue engineering scaffolds by means of rapid prototyping techniques. J Mater Sci2002; 37(15): 3107–3116.
32.
QuarlesLDYohayDALeverLW. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res1992; 7(6): 683–692.
33.
WangJYuX.Preparation, characterization and in vitro analysis of novel structured nanofibrous scaffolds for bone tissue engineering. Acta Biomater2010; 6(8): 3004–3012.
34.
JunquieraLCJunqueiraLCBrentaniRR.A simple and sensitive method for the quantitative estimation of collagen. Anal Biochem1979; 94(1): 96–99.
35.
PuppiDPirasAMDettaN. Poly(vinyl alcohol)-based electrospun meshes as potential candidate scaffolds in regenerative medicine. J Bioact Compat Polym2011; 26(1): 20–34.
36.
VolpatoFRamosSLMottaA. Physical and in vitro biological evaluation of a PA 6/MWCNT electrospun composite for biomedical applications. J Bioact Compat Polym2011; 26(1): 35–47.
37.
GuarinoVAlvarez-PerezMCirilloV. hMSC interaction with PCL and PCL/gelatin platforms: a comparative study on films and electrospun membranes. J Bioact Compat Polym2011; 26(2): 144–160.
BiancoABozzoBMDel GaudioC. Poly (l-lactic acid)/calcium-deficient nanohydroxyapatite electrospun mats for bone marrow stem cell cultures. J Bioact Compat Polym2011; 26(3): 225–241.
40.
HualinZ.Electrospun poly(lactic-co-glycolic acid)/multiwalled carbon nanotubes composite scaffolds for guided bone tissue regeneration. J Bioact Compat Polym2011; 26(4): 347–362.
41.
PirasAMChielliniFChielliniE. New multicomponent bioerodible electrospun nanofibers for dual-controlled drug release. J Bioact Compat Polym2008; 23(5): 423–443.
42.
MotaCPuppiDDinucciD. Dual-scale polymeric constructs as scaffolds for tissue engineering. Materials2011; 4(3): 527–542.
43.
SmoldersCAReuversAJBoomRM.Microstructures in phase-inversion membranes. Part 1.Formation of macrovoids. J Memb Sci1992; 73(2–3): 259–275.
44.
KimHJTyagiRKFoudaAE. The kinetic study for asymmetric membrane formation via phase-inversion process. J Appl Polym Sci1996; 62(4): 621–629.
45.
HouCLiangYWangC-G.Determination of the diffusion coefficient of H2O in polyacrylonitrile fiber formation. J Polym Res2005; 12(1): 49–52.
46.
ArbabSZeinolebadiANoorpanahP.Exploring the thermodynamic aspects of structure formation during wet-spinning of polyacrylonitrile fibres. Int J Chemoinform Chem Eng2011; 1(2): 36–52.
47.
HouCQuRWangC. Diffusion coefficient of DMF in acrylic fiber formation. J Appl Polym Sci2006; 101(6): 3616–3619.
48.
ArbabSNoorpanahPMohammadiN. Designing index of void structure and tensile properties in wet-spun polyacrylonitrile (PAN) fiber. I. Effect of dope polymer or nonsolvent concentration. J Appl Polym Sci2008; 109(6): 3461–3469.
49.
KimJHLeeKH.Effect of PEG additive on membrane formation by phase inversion. J Memb Sci1998; 138(2): 153–163.
50.
MulderM. Influence of various parameters on membrane morphology. In: MulderM (ed.) Basic principle of membrane technology. 2nd ed.Dordrecht: Kluwer Academic, 1996, pp. 123–140.
51.
ReuversAJSmoldersCA. Formation of membranes by means of immersion precipitation: part II. The mechanism of formation of membranes prepared from the system cellulose acetate-acetone-water. J Memb Sci1987; 34(1): 67–86.
52.
StrathmannHKockKAmarP. The formation mechanism of asymmetric membranes. Desalination1975; 16(2): 179–203.
53.
ZeinIHutmacherDWTanKC. Fused deposition modeling of novel scaffold architectures for tissue engineering applications. Biomaterials2002; 23(4): 1169–1185.
54.
DomingosMChielliniFGloriaA. Effect of process parameters on the morphological and mechanical properties of 3D bioextruded poly(ε-caprolactone) scaffolds. Rapid Prototyping J2012; 18(1): 56–67.
55.
ShorLGuceriSWenX. Fabrication of three-dimensional polycaprolactone/hydroxyapatite tissue scaffolds and osteoblast-scaffold interactions in vitro. Biomaterials2007; 28(35): 5291–5297.
56.
KyriakidouKLucariniGZizziA. Dynamic co-seeding of osteoblast and endothelial cells on 3D polycaprolactone scaffolds for enhanced bone tissue engineering. J Bioact Compat Polym2008; 23(3): 227–243.
57.
DomingosMChielliniFGloriaA. BioExtruder: study of the influence of process parameters on PCL scaffolds properties. In: BartoloPJ (ed.) Innovative developments in design and manufacturing – advanced research in virtual and rapid prototyping. Oxford: Taylor & Francis, 2009, pp. 67–73.
58.
GloriaARussoTDe SantisR. 3D fiber deposition technique to make multifunctional and tailor-made scaffolds for tissue engineering applications. J Appl Biomater Biomech2009; 7(3): 141–152.
59.
BartoloPDomingosMGloriaA. BioCell printing: integrated automated assembly system for tissue engineering constructs. CIRP Ann: Manuf Techn2011; 60(1): 271–274.
60.
HutmacherDWSchantzTZeinI. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. J Biomed Mater Res2001; 55(2): 203–216.
61.
CoombesAGARizziSCWilliamsonM. Precipitation casting of polycaprolactone for applications in tissue engineering and drug delivery. Biomaterials2004; 25(2): 315–325.
62.
ZongX-HWangZ-GHsiaoBS. Structure and morphology changes in absorbable poly(glycolide) and poly(glycolide-co-lactide) during in vitro degradation. Macromolecules1999; 32(24): 8107–8114.
63.
PeñaJCorralesTIzquierdo-BarbaI. Long term degradation of poly(ε-caprolactone) films in biologically related fluids. Polym Degrad Stab2006; 91(7): 1424–1432.
64.
RissanenMPuolakkaAHukkaT. Effect of process parameters on properties of wet-spun poly(l,d-lactide) copolymer multifilament fibers. J Appl Polym Sci2009; 113(4): 2683–2692.
65.
GaoHGuYPingQ.The implantable 5-fluorouracil-loaded poly(l-lactic acid) fibers prepared by wet-spinning from suspension. J Control Release2007; 118(3): 325–332.
66.
KommareddyKPLangeCRumplerM. Two stages in three-dimensional in vitro growth of tissue generated by osteoblastlike cells. Biointerphases2010; 5(2): 45–52.
67.
BeckGRSullivanECMoranE. Relationship between alkaline phosphatase levels, osteopontin expression, and mineralization in differentiating MC3T3-E1 osteoblasts. J Cell Biochem1998; 68(2): 269–280.
68.
AlcaínFJBurónMI.Ascorbate on cell growth and differentiation. J Bioenerg Biomembr1994; 26(4): 393–398.
69.
CalvertJWChuaWCGharibjanianNA. Osteoblastic phenotype expression of MC3T3-E1 cells cultured on polymer surfaces. Plast Reconstr Surg2005; 116(2): 567–576.
70.
WutticharoenmongkolPPavasantPSupapholP.Osteoblastic phenotype expression of MC3T3-E1 cultured on electrospun polycaprolactone fiber mats filled with hydroxyapatite nanoparticles. Biomacromolecules2007; 8(8): 2602–2610.
71.
ParkJB.The effects of dexamethasone, ascorbic acid, and beta-glycerophosphate on osteoblastic differentiation by regulating estrogen receptor and osteopontin expression. J Surg Res2012; 173(1): 99–104.
